In the past week, HIMS stock has gone up by 25.47%, with a monthly gain of 12.64% and a quarterly surge of 51.03%. The volatility ratio for the week is 13.25%, and the volatility levels for the last 30 days are 11.16% for Hims & Hers Health Inc The simple moving average for the last 20 days is 7.15% for HIMS stock, with a simple moving average of 39.18% for the last 200 days.
Is It Worth Investing in Hims & Hers Health Inc (NYSE: HIMS) Right Now?
Hims & Hers Health Inc (NYSE: HIMS) has a price-to-earnings ratio that is above its average at 56.07x. The stock has a 36-month beta value of 1.11. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 2 as “overweight,” 8 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HIMS is 177.25M, and at present, short sellers hold a 19.09% of that float. On November 22, 2024, the average trading volume of HIMS was 13.53M shares.
HIMS) stock’s latest price update
Hims & Hers Health Inc (NYSE: HIMS)’s stock price has plunge by 0.37relation to previous closing price of 24.15. Nevertheless, the company has seen a 25.47% surge in its stock price over the last five trading sessions. zacks.com reported 2024-11-22 that Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock’s prospects.
Analysts’ Opinion of HIMS
Needham, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $24. The rating they have provided for HIMS stocks is “Buy” according to the report published on August 22nd, 2024.
HIMS Trading at 18.09% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.37% of loss for the given period.
Volatility was left at 11.16%, however, over the last 30 days, the volatility rate increased by 13.25%, as shares surge +11.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +46.47% upper at present.
During the last 5 trading sessions, HIMS rose by +25.62%, which changed the moving average for the period of 200-days by +146.40% in comparison to the 20-day moving average, which settled at $22.62. In addition, Hims & Hers Health Inc saw 172.36% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Chi Michael, who sale 7,500 shares at the price of $22.00 back on Nov 19 ’24. After this action, Chi Michael now owns 183,980 shares of Hims & Hers Health Inc, valued at $165,000 using the latest closing price.
Baird Melissa, the Chief Operating Officer of Hims & Hers Health Inc, sale 58,750 shares at $21.04 during a trade that took place back on Nov 18 ’24, which means that Baird Melissa is holding 630,166 shares at $1,236,364 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.78 for the gross margin
The net margin for Hims & Hers Health Inc stands at 0.08. The total capital return value is set at 0.08. Equity return is now at value 26.35, with 19.93 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at 105.2.
Currently, EBITDA for the company is -19.94 million with net debt to EBITDA at -2.95. When we switch over and look at the enterprise to sales, we see a ratio of 4.0. The receivables turnover for the company is 271.53for trailing twelve months and the total asset turnover is 2.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.14.
Conclusion
To sum up, Hims & Hers Health Inc (HIMS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
